Prothena Corporation plc

PRTA ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021 Dec 2020 Sep 2020
Operating Activities
Net Income $-41.2M $-36.3M $-33.2M $109.2M $27.6M $-36.7M $-30.7M $-30.6M
Depreciation & Amortization $184.0K $182.0K $240.0K $280.0K $291.0K $304.0K $362.0K $387.0K
Depreciation $200.0K $200.0K $200.0K $300.0K $300.0K $300.0K $300.0K $400.0K
Amortization — — — — — — — —
Stock-Based Compensation $8.3M $7.7M $6.9M $6.1M $5.5M $6.2M $5.2M $5.6M
Net Cash from Operating Activities $-35.3M $-37.4M $-22.5M $112.1M $36.6M $-33.7M $-19.1M $-19.4M
Investing Activities
Capital Expenditures — — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-161.0K $-22.0K $-319.0K $-208.0K $0 $-48.0K $-51.0K $-77.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $1.2M $1.3M $1.8M $87.0M $20.2M $81.3M $0 $64.0K
Net Change in Cash — — — — — — — $-19.4M
Free Cash Flow — — — — — — — —
← Newer Page 3 of 8 Older →